These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240 [Abstract] [Full Text] [Related]
7. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies. Nouso K, Matsumoto E, Kobayashi Y, Nakamura S, Tanaka H, Osawa T, Ikeda H, Araki Y, Sakaguchi K, Shiratori Y. J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599 [Abstract] [Full Text] [Related]
9. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI. Radiology; 2014 Mar; 270(3):900-9. PubMed ID: 24475823 [Abstract] [Full Text] [Related]
10. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure? Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G. Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300 [Abstract] [Full Text] [Related]
11. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial]. Lü MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, Li DM, Lai JM, Li SQ. Zhonghua Yi Xue Za Zhi; 2006 Mar 28; 86(12):801-5. PubMed ID: 16681964 [Abstract] [Full Text] [Related]
12. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Izumi N, Asahina Y, Noguchi O, Uchihara M, Kanazawa N, Itakura J, Himeno Y, Miyake S, Sakai T, Enomoto N. Cancer; 2001 Mar 01; 91(5):949-56. PubMed ID: 11251946 [Abstract] [Full Text] [Related]
14. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation. Facciorusso A, Del Prete V, Antonino M, Crucinio N, Neve V, Di Leo A, Carr BI, Barone M. Dig Liver Dis; 2014 Nov 01; 46(11):1014-9. PubMed ID: 25085684 [Abstract] [Full Text] [Related]
17. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS. J Gastroenterol Hepatol; 2011 Nov 01; 26(11):1638-45. PubMed ID: 22011297 [Abstract] [Full Text] [Related]
19. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma. Xu Y, Shen Q, Wang N, Wu PP, Huang B, Kuang M, Qian GJ. Chin J Cancer; 2017 Jan 19; 36(1):14. PubMed ID: 28103953 [Abstract] [Full Text] [Related]